Gestmarck Aq 25 Injection
Marketer
Bismarck Pharmaceuticals Pvt. Ltd.
Salt Composition
Progesterone (Natural Micronized) (25mg)
Overview Gestmarck Aq 25 Injection
Ovulation and menstruation are regulated by the natural female hormone found in Gestmarck Aq 25 Injection. This injectable medication aids in restoring menstrual cycles in women experiencing amenorrhea and is employed in infertility treatment. Administration must be performed by a medical professional; self-injection is strictly prohibited. Follow your physician's prescribed dosage and duration precisely. Continued use post-conception may be necessary. Common side effects, potentially manageable with your doctor's guidance, include abdominal discomfort, backache, breast sensitivity, low blood pressure, lightheadedness, increased clotting tendency, and uterine bleeding. Severe allergic reactions necessitate immediate medical care. Prior to commencing treatment, disclose any history of breast cancer, abnormal uterine bleeding, or liver, kidney, or heart conditions. Complete medication disclosure is crucial due to potential drug interactions. Pre- and ongoing treatment monitoring will involve various tests. Given the potential for drowsiness and impaired cognitive function, avoid driving or operating machinery while using Gestmarck Aq 25 Injection.
Uses of Gestmarck Aq 25 Injection
Managing hormonal imbalances | Restoring female reproductive function
Major Benefits of Gestmarck Aq 25 Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Gestmarck Aq 25 Injection:
- Abdominal pain
- Breast tenderness
- Dizziness
- Abdominal cramp
- Back pain
- Hypotension (low blood pressure)
- Vaginal bleeding
How to use Gestmarck Aq 25 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Gestmarck Aq 25 Injection works:
Gestmarck Aq 25 Injection contains progesterone, a key female hormone. This medication supports pregnancy establishment and continuation. Furthermore, it counteracts estrogen-induced endometrial thickening.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Gestmarck Aq 25 Injection lacks established safety data. Physician consultation is advised.
PregnancySAFE IF PRESCRIBED
Gestmarck Aq 25 Injection poses minimal to no developmental risk to the fetus, according to the majority of research on its use during pregnancy.
Breast feedingSAFE IF PRESCRIBED
Gestmarck Aq 25 Injection poses no known breastfeeding risk. Research in humans indicates minimal drug transfer to breast milk, presenting no apparent harm to the infant.
DrivingUNSAFE
Administering Gestmarck Aq 25 Injection could lead to reduced awareness, visual impairment, drowsiness, and dizziness. Driving should be avoided if such effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Gestmarck Aq 25 Injection to individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Gestmarck Aq 25 Injection to individuals with hepatic impairment. Seek medical advice from your physician.
What if you forget to take Gestmarck Aq 25 Injection :
NA
Facts to Know About Gestmarck Aq 25 Injection
| Label | Value |
|---|---|
| Chemical Type | Progestin |
| Developing Habits | No. |
| Type of Therapy | Obstetrics and Gynecology |
| Action Class | Bioidentical Progesterone |


